Dr. Matt Warkentin says in those without significant comorbidity and who are fit for surgery, screening may provide survival benefits.
Dr. Katie Smith says pragmatic clinical trials reveal the impact of symptom burden in young patients.
Dr. Li said a considerable global burden of asbestos-related lung cancers and mesothelioma persists, even as beneficial impact of national asbestos bans are awaited.
Experts, including Dr. Melina E. Marmarelis, revealed different approaches to overcoming resistance to immune checkpoint inhibitors.
Dr. Ziming Li and other panelists recently explored encouraging clinical trial data for novel therapies, including garsorasib, olomorasib, fulzerasib, and divarasib.
During the 2024 WCLC, Dr. Shalini Vinod reviewed data showing that a nurse-led care model for geriatric patients outperformed a medical-led model.
Dr. Geoffrey Liu presented results from the TRUST-II trial on the safety and efficacy of taletrectinib in TKI-naive and TKI-pretreated patients.
IASLC Communications Committee members gathered during a WCLC 2024 workshop to share tips on tailoring messages to different audiences, building a strong social media presence, and more.
Global leaders in patient advocacy assembled during the 2024 World Conference on Lung Cancer to shed light on ongoing initiatives.
Dr. Yixian Crystal Chen recently presented results that demonstrate fine particulate matter poses health risks, even for those with no smoking history.